Title: Sanofi-aventis - Comment
Abstract: Brian E. Harvey, M.D., Ph.D., Vice President, Regulatory Policy...Sanofi-aventis U.S. LLC appreciates the opportunity to comment on the above-referenced proposed rule....
Details Information
Attachments:
Sanofi-aventis - Comment
View Attachment:Comments
Related Documents